Clinical Trial Update: Cockroach Immunotherapy in Children and Adolescents [Phase 2]

View source ↗

Summary

Phase 2 trial update for cockroach immunotherapy in children/adolescents with persistent asthma; trial completed with results posted in 2023.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Persistent Asthma

Drugs mentioned

• Cockroach immunotherapy

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Persistent Asthma | Phase 2 | Status: COMPLETED | Results posted: 2023-05-22